TheStreet home
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

LATEST NEWS

How to Think About Stocks as President Trump Announces Military Strikes on Syria
POLITICS

What to expect from Trump's speech on drug prices on Friday

Opioid Litigants Get Boost From Senate Report
OPINION

Opioid litigants get boost from Senate report

These Are the Biggest Winners and Losers in Activist Investing This Year
MERGERS AND ACQUISITIONS

These Are the Biggest Winners and Losers in Activist Investing This Year

Here's How You Can Easily Tell Golf Addict President Trump Absolutely Loves the Masters
REGULATION

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: FibroGen Leaps on Results for Pulmonary Fibrosis Study

Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER
HEALTH

Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER

Young Guns of Activism Join Boards at AIG, SunOpta and DepoMed
MERGERS AND ACQUISITIONS

The Young Guns of Activism

Depomed Focuses on Flagship Drug Rather Than M&A: CEO
MERGERS AND ACQUISITIONS

Beefing Up Nucynta Franchise, Not M&A Is Depomed's Focus Now

Mylan's Shares Rise Despite FTC Investigation
STOCKS

Biotech Movers: Depomed Shares Tank After Earnings Get Even Worse

Analysts' Actions -- Amazon, CVS, Raytheon, Western Digital and More
STOCKS

Analysts' Actions -- Allergan, Coach, General Dynamics, Occidental and More

Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector
POLITICS

Opioid Makers Fall After FDA Pick Gottlieb Says America's Drug Addiction Is Out of Control

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Premarket Movers: Sage Therapeutics, Depomed, NantKwest

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Premarket Movers: Vertex, Sangamo, Depomed

Senator McCaskill Launching Investigation Into Opioid Drugmakers
MERGERS AND ACQUISITIONS

Depomed switches out CEO and board in making peace with activist Starboard

Senator McCaskill Launching Investigation Into Opioid Drugmakers
STOCKS

Senator McCaskill Launching Investigation Into Opioid Drugmakers

Hikma Shakes Up U.S. Operations After FDA Disappointment; CEO Said Darwazah to Lead Group
MERGERS AND ACQUISITIONS

A Deal is Imminent For Depomed, CFO Says

Argos Plummets 72%, Leads Biotech Movers
STOCKS

Biotech movers: Argos plummets 72%

Drug Giant Eli Lilly Wants to Save Money So it Brought in These New Bigwigs
STOCKS

Pain med company Depomed reports adjusted earnings of $1.15 per share

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members
MERGERS AND ACQUISITIONS

Perrigo settles with activist investor Starboard

Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix
STOCKS

Biotech stock mailbag: Trump, Aurinia, Immunomedics, Cellceutix

Dow Industrials Hit 20,000 for the First Time in History
FUTURES

Dow's march to 20,000 hits another snag as crude settles at two-week low

Stocks Mixed Again as Dow Declines but Nasdaq Remains on Track for Record Close
FUTURES

Dow's attempt at 20,000 fades as crude reverses course

Stocks Ease Off Highs as Dow 20,000 Remains a Challenge
FUTURES

Stocks ease off highs as Dow 20,000 remains a challenge

5 Things You Must Know Before the Market Opens Friday
FUTURES

Stock futures rise ahead of first trading day of 2017

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members
MERGERS AND ACQUISITIONS

Ranking the activists for proxy season 2016